| Not Yet Recruiting | A Study of Uveitis in Children <18 Years of Age NCT07518134 | Jaeb Center for Health Research | — |
| Not Yet Recruiting | Wide Field OCTA in Ocular Diseases NCT07298174 | IRCCS San Raffaele | — |
| Active Not Recruiting | Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles NCT07262437 | University of Milan | N/A |
| Active Not Recruiting | Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in Singapore NCT07176130 | Singapore National Eye Centre | — |
| Recruiting | Metagenomics for Ocular Inflammation NCT06974162 | Moorfields Eye Hospital NHS Foundation Trust | — |
| Not Yet Recruiting | Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis NCT06390436 | Centre Hospitalier Universitaire de Saint Etienne | Phase 4 |
| Active Not Recruiting | Study of Risk Factors for Therapeutic Failure in Chronic Non-Infectious Uveitis After First-Line Immunosuppres NCT06821971 | Centre Hospitalier Universitaire, Amiens | — |
| Active Not Recruiting | A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis NCT06431373 | Priovant Therapeutics, Inc. | Phase 3 |
| Completed | Vitamin and Unsaturated Fatty Acid Supplements in Healthy and Uveitis Human Subjects NCT06491979 | Tianjin Medical University | N/A |
| Recruiting | Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study NCT06161415 | Quan Dong Nguyen | Phase 1 |
| Active Not Recruiting | Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis NCT06310837 | Zhongshan Ophthalmic Center, Sun Yat-sen University | N/A |
| Completed | Nailfold Capillaroscopic Assessment in Pediatric Uveitis Patients NCT06070935 | Assiut University | — |
| Unknown | Relevance and Efficiency of SecOnd Line Workup for Uveitis NCT06102408 | Central Hospital, Nancy, France | — |
| Unknown | Different Treatment Approaches of Presumed Trematode-Induced Uveitis NCT06260449 | Assiut University | N/A |
| Completed | Characteristics of Ankylosing Spondylitis Associated Uveitis NCT07113834 | Benha University | — |
| Recruiting | The Cohort Study of Uveitis Patients NCT05727540 | Zhongshan Ophthalmic Center, Sun Yat-sen University | — |
| Recruiting | A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis NCT05592717 | Tianjin Medical University | — |
| Unknown | Safety and Efficacy of Adalimumab Therapy for Treatment of Behcet's Disease-related Uveitis in Sohag Universit NCT05683626 | Sohag University | — |
| Recruiting | The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting th NCT05486468 | Texas Retina Associates | Phase 3 |
| Withdrawn | Intravitreal Sirolimus as Therapeutic Approach to Uveitis NCT01280669 | Stanford University | Phase 2 |
| Terminated | Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis NCT05384249 | ACELYRIN Inc. | Phase 2 |
| Recruiting | Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing NCT05286203 | University of California, San Francisco | N/A |
| Recruiting | Screening for Oculocerebral Lymphoma with the Phenotype of NK Cells in Patients with Uveitis NCT05388838 | Hospices Civils de Lyon | N/A |
| Unknown | Retrospective Comparison of the Efficacy of Methotrexate and Azathioprine as Background Treatment for Uveitis NCT05370690 | University Hospital, Brest | — |
| Unknown | Outcome of Treatment of Uveitis With Biologic Drugs in Resistant Cases Vogt-koyanagi-Harada Disease NCT05349747 | Assiut University | — |
| Recruiting | RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age NCT06273748 | Meyer Children's Hospital IRCCS | — |
| Unknown | Efficacy, Safety and Costs of Methotrexate, Adalimumab, or Their Combination in Non-infectious Non-anterior Uv NCT04798755 | Hospital San Carlos, Madrid | Phase 3 |
| Completed | A Trial of the Efficacy and Safety of Izokibep in the Treatment of Non-anterior Uveitis NCT04706741 | ACELYRIN Inc. | Phase 2 |
| Active Not Recruiting | Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV) NCT05180526 | Bio-Thera Solutions | Phase 4 |
| Recruiting | Minocycline for Chronic Autoimmune Uveitis NCT05474729 | Sun Yat-sen University | Phase 1 / Phase 2 |
| Unknown | High Resolution Optical Coherence Tomography NCT05130385 | Insel Gruppe AG, University Hospital Bern | — |
| Unknown | Mutation Detection for VRL NCT05102994 | Sun Yat-sen University | — |
| Not Yet Recruiting | Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Behçet's Uveitis NCT05105347 | Peking Union Medical College Hospital | Phase 4 |
| Terminated | Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert NCT05070728 | EyePoint Pharmaceuticals, Inc. | Phase 3 |
| Withdrawn | Microbiome as a ThErapeutic Response Biomarker NCT04721743 | National Eye Institute (NEI) | — |
| Unknown | Development of AI Model for Uveitis Progression and Prognosis NCT04705103 | Sun Yat-sen University | — |
| Unknown | Reduction or Discontinuation of TNF-α Inhibitor in Non-infectious Uveitis Patients NCT05155592 | Dan Liang | Phase 2 |
| Completed | Biomarkers in Ocular Inflammation and Uveitis NCT04690829 | National Eye Institute (NEI) | — |
| Active Not Recruiting | UNICORNS: Uveitis in Childhood Prospective National Cohort Study NCT05385757 | Institute of Child Health | — |
| Recruiting | AutoInflammatory Disease Alliance Registry (AIDA) NCT05200715 | University of Siena | — |
| Completed | Adalimumab in JIA-associated Uveitis Stopping Trial NCT03816397 | Nisha Acharya | Phase 4 |
| Terminated | Golimumab for the Treatment of Refractory Behcet's Uveitis NCT04218565 | Wenjie Zheng | Phase 2 |
| Completed | Medication Compliance in the Paediatric Uveitis Population Reported by the Patients and Parents NCT04148365 | Manchester University NHS Foundation Trust | — |
| Unknown | Adalimumab Plus Methotrexate for the Treatment of Pediatric Uveitis NCT04588818 | Sun Yat-sen University | Phase 2 |
| Unknown | Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Non-infectious and Idiopathic Uveitis NCT04162314 | Fakultas Kedokteran Universitas Indonesia | Phase 2 / Phase 3 |
| Unknown | Acute and Chronic Inflammatory Disease, Lifestyle and Treatment Response NCT04193020 | Wroclaw Medical University | — |
| Completed | Six-months Versus Nine-months ATT for Ocular TB NCT06613919 | L.V. Prasad Eye Institute | Phase 4 |
| Active Not Recruiting | A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Asso NCT04088409 | Eli Lilly and Company | Phase 3 |
| Terminated | Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF NCT04296838 | Peking Union Medical College Hospital | Phase 2 / Phase 3 |
| Unknown | Biomarkers of Common Eye Diseases NCT04101604 | Sun Yat-sen University | — |
| Active Not Recruiting | Imaging Quantification of Inflammation (IQI) NCT04704609 | The Cleveland Clinic | — |
| Completed | Adalimumab vs. Conventional Immunosuppression for Uveitis Trial NCT03828019 | JHSPH Center for Clinical Trials | Phase 3 |
| Completed | Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant NCT04340505 | The Cleveland Clinic | — |
| Unknown | Tofacitinib for Inflammatory Eye Disease NCT03580343 | Washington University School of Medicine | Phase 2 |
| Completed | Monitoring Drug-induced Uveitis NCT03899922 | Groupe Hospitalier Pitie-Salpetriere | — |
| Completed | Abatacept in Patients With Birdshot HLA A29 Uveitis NCT03871361 | Universitaire Ziekenhuizen KU Leuven | Phase 2 |
| Completed | Assessment of the Anti-inflammatory Effects of Norflo Oro in Acute Relapses of HLA-B27 Associated Autoimmune U NCT03584724 | Eye Pharma | EARLY_Phase 1 |
| Completed | OCT Technology Development to Assess Ocular Integrity and Characterize Ocular Integrity and Intraocular Scatte NCT03531853 | Duke University | N/A |
| Unknown | A Clinical Trial of Metformin to Decrease Glucocorticoids Side Effects in Patients With Autoimmune Uveitis NCT03525028 | Tianjin Medical University | N/A |
| Unknown | Feasibility Study and Preliminary Application Study on Iris OCTA NCT03631108 | Shanghai Eye Disease Prevention and Treatment Center | — |
| Terminated | Macular Edema Nepafenac vs. Difluprednate Uveitis Trial NCT01939691 | University of California, San Francisco | Phase 4 |
| Unknown | Objective Choroidal Thickness Measurements in Uveitis NCT03889860 | Wroclaw Medical University | — |
| Terminated | Tocilizumab for the Treatment of Refractory Behcet's Uveitis NCT03554161 | Wenjie Zheng | Phase 2 |
| Completed | Psychosocial Outcomes and Transition Readiness in Uveitis NCT03554824 | Sheffield Children's NHS Foundation Trust | — |
| Completed | MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301 NCT02952001 | Clearside Biomedical, Inc. | — |
| Completed | ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study) NCT02931175 | Quan Dong Nguyen | Phase 2 |
| Completed | Chronic Inflammatory Disease, Lifestyle and Treatment Response NCT03173144 | University of Southern Denmark | — |
| Completed | Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis NCT03209219 | Peking Union Medical College Hospital | Phase 3 |
| Completed | Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveit NCT02929251 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Completed | Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Report NCT03155243 | AbbVie | — |
| Terminated | LSFG-SKIN, Laser Speckle Flowgraphy NCT03660618 | Randy Kardon | N/A |
| Withdrawn | Factors Affecting Aqueous Humor Outflow Facility in Patients with Uveitis NCT02613442 | University of Nebraska | — |
| Completed | Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis NCT03097315 | Clearside Biomedical, Inc. | Phase 3 |
| Completed | Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis (STAR Study) NCT02911116 | National Eye Institute (NEI) | Phase 2 |
| Completed | Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial NCT02623426 | JHSPH Center for Clinical Trials | Phase 3 |
| Unknown | A Clinical Trial of Acyclovir for Viral Uveitis NCT03389191 | Xiaomin Zhang | N/A |
| Unknown | A Clinical Trial of Infliximab for Childhood Uveitis NCT04150770 | Xiaomin Zhang | Phase 4 |
| Completed | Outcome of Different IOLs in Patients With and Without Uveitis NCT02975895 | Vastra Gotaland Region | N/A |
| Completed | HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis NCT02916017 | AbbVie | — |
| Unknown | Conbercept in Choroidal Neovascularization Secondary to Uveitis NCT02934841 | Chongqing Medical University | Phase 2 |
| Terminated | Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography NCT02907814 | Rutgers, The State University of New Jersey | N/A |
| Completed | Uveitis/Intraocular Inflammatory Disease Biobank (iBank) NCT02656381 | National Eye Institute (NEI) | — |
| Completed | Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients NCT02764697 | Tampa Bay Uveitis Center, LLC | Phase 4 |
| Terminated | Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis NCT02769702 | Washington University School of Medicine | Phase 4 |
| Completed | Evaluation of Corneal Endothelial Cell Density in Subjects Who Have Had a Fluocinolone Acetonide Implant NCT01060787 | Bausch & Lomb Incorporated | — |
| Recruiting | Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis NCT02706704 | American University of Beirut Medical Center | Phase 2 |
| Recruiting | Lyon Uveitis Study NCT03877575 | Hospices Civils de Lyon | — |
| Withdrawn | Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid M NCT02598869 | Oregon Health and Science University | Phase 4 |
| Completed | Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis NCT02595398 | Clearside Biomedical, Inc. | Phase 3 |
| Completed | Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital NCT02998398 | Assistance Publique - Hôpitaux de Paris | — |
| Unknown | Use of Simvastatin as a Steroid Sparing Agent for Uveitis Patients NCT02252328 | University College, London | Phase 2 / Phase 3 |
| Completed | Phenomics in Autoimmune and Inflammatory Diseases NCT02466217 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial NCT02374060 | JHSPH Center for Clinical Trials | Phase 3 |
| Completed | RNFL Thickness Measurements Obtained Using SD-OCT and SLP Using GDx Variable Corneal Compensation NCT03206268 | Hospices Civils de Lyon | — |
| Completed | Childhood Uveitis Initial Management and One-year Outcomes NCT02490254 | Moorfields Eye Hospital NHS Foundation Trust | — |
| Withdrawn | Grading Scale of Vitreous Haze in Patients With Uveitis Using Ultrasonography NCT02311192 | University of Nebraska | N/A |
| Completed | Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uv NCT02255032 | Clearside Biomedical, Inc. | Phase 2 |
| Completed | Simvastatin in Uveitis NCT04183387 | Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology | Phase 2 |
| Terminated | An Open-label, Rollover Study Providing Continued Dosing of Gevokizumab in Order to Assess Long-term Gevokizum NCT02258854 | XOMA (US) LLC | Phase 3 |
| Completed | Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis NCT01900431 | Sanofi | Phase 2 |
| Completed | Intestinal Bacteria and Ocular Inflammatory Disease NCT01859299 | National Eye Institute (NEI) | — |
| Completed | Methotrexate and Mycophenolate Mofetil for UVEITIS NCT01829295 | University of California, San Francisco | Phase 3 |
| Completed | Microbiological Diagnosis of Infectious Uveitis to Pathogenic Fastidious Germs NCT02819206 | Assistance Publique Hopitaux De Marseille | N/A |
| Completed | Flare Photometry in Uveitis Patients NCT01897935 | ChromoLogic, LLC | — |
| Completed | TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema NCT01870440 | Northern California Retina Vitreous Associates | Phase 4 |
| Completed | Ocular Manifestations in Rheumatic Diseases NCT03753893 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | — |
| Completed | Correlation Between Aqueous Protein Level and Clinical Grading of Flare and Flaremetry. NCT01905579 | The Eye Center and The Eye Foundation for Research in Ophthalmology | N/A |
| Suspended | Treatment of the Bilateral Severe Uveitis by IVT of Regulator T-cells: Study of Tolerance of Dose NCT02494492 | Assistance Publique - Hôpitaux de Paris | Phase 1 / Phase 2 |
| Completed | Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis NCT01789320 | Clearside Biomedical, Inc. | Phase 1 / Phase 2 |
| Completed | Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study NCT02620618 | Cairo University | Phase 1 / Phase 2 |
| Terminated | Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment NCT01747538 | XOMA (US) LLC | Phase 3 |
| Terminated | Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis NCT01684345 | XOMA (US) LLC | Phase 3 |
| Withdrawn | Ustekinumab for Active Sight-Threatening Uveitis NCT01647152 | National Eye Institute (NEI) | Phase 1 / Phase 2 |
| Recruiting | Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography NCT01746537 | The Cleveland Clinic | — |
| Unknown | Causes of Visual Loss in Retinal Disease NCT01613963 | Royal Surrey County Hospital NHS Foundation Trust | — |
| Unknown | Optical Coherence Tomography (OCT) in Uveitis NCT02026128 | Oregon Health and Science University | — |
| Completed | Abatacept in the Treatment of Uveitis NCT01279954 | Oregon Health and Science University | Phase 2 |
| Completed | Clinical Outcome in Uveitis NCT01983488 | Moorfields Eye Hospital NHS Foundation Trust | — |
| Completed | Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis NCT01385826 | Assistance Publique - Hôpitaux de Paris | Phase 2 / Phase 3 |
| Completed | Topical Interferon Gamma for Macular Edema Secondary to Uveitis NCT01376362 | National Eye Institute (NEI) | Phase 1 / Phase 2 |
| Withdrawn | Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis NCT01327664 | Novartis Pharmaceuticals | Phase 3 |
| Recruiting | Genetics of Uveitis NCT02357238 | The Cleveland Clinic | — |
| Terminated | Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema NCT01194674 | National Institutes of Health Clinical Center (CC) | Phase 1 / Phase 2 |
| Completed | Prevalence of Toxoplasma Gondii and Toxocara Canis Among Patients With Uveitis NCT01837056 | National Institute of Health, Korea | — |
| Withdrawn | Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis NCT01103024 | Novartis | Phase 3 |
| Completed | A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan- NCT01148225 | AbbVie | Phase 3 |
| Withdrawn | Autofluorescence in Uveitic and Diabetic Macular Edema NCT00956124 | St. Franziskus Hospital | — |
| Completed | First-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot Trial NCT01232920 | University of California, San Francisco | Phase 3 |
| Completed | Optiquel® as Corticosteroid-sparing Therapy for Chronic Noninfectious Uveitis NCT01195948 | National Eye Institute (NEI) | Phase 1 / Phase 2 |
| Completed | Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis NCT01124838 | AbbVie (prior sponsor, Abbott) | Phase 3 |
| Completed | Efficacy and Safety of Adalimumab in Patients With Active Uveitis NCT01138657 | AbbVie (prior sponsor, Abbott) | Phase 3 |
| Completed | Evaluation of a Standardized Strategy for Uveitis Etiological Diagnosis NCT01162070 | Hospices Civils de Lyon | N/A |
| Terminated | Immunogenetic Mechanisms in Behcet's Disease NCT01109433 | National Eye Institute (NEI) | — |
| Terminated | Efficacy, Safety and Tolerability of Repeated Dosis of Intravitreous Bevacizumab in Uveitic Macular Oedema NCT01095809 | Hospital Clinic of Barcelona | Phase 3 |
| Terminated | Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis NCT01095250 | Novartis Pharmaceuticals | Phase 3 |
| Terminated | 38 Week Extension Study to CAIN457C2303 NCT01093846 | Novartis Pharmaceuticals | Phase 3 |
| Withdrawn | Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids NCT00846625 | University of Utah | Phase 2 |
| Terminated | Apremilast in the Treatment of Uveitis NCT00889421 | Oregon Health and Science University | Phase 1 / Phase 2 |
| Completed | The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma NCT00943982 | National Eye Institute (NEI) | Phase 1 |
| Unknown | Uveitis in Relation to Perceived Stress: A Prospective Study NCT01025986 | The New York Eye & Ear Infirmary | — |
| Completed | Sirolimus as Therapeutic Approach to Uveitis NCT00908466 | Johns Hopkins University | Phase 1 |
| Completed | Assessment of Retinal Nerve Fibre Layer by Optical Coherence Tomography in Uveitis Patients With Papilloedema NCT01170481 | St. Franziskus Hospital | — |
| Completed | Observation on the Treg in the Uveitis Patients NCT01306474 | Xijing Hospital | — |
| Completed | Ultrastructural Changes of Trabeculectomy Specimens in Patients With Uveitic Secondary Glaucoma NCT00917670 | St. Franziskus Hospital | — |
| Completed | Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema NCT00790803 | Wake Forest University | N/A |
| Unknown | Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot S NCT00855608 | Rafic Hariri University Hospital | Phase 1 |
| Unknown | Mycophenolate Sodium (Myfortic®) in the Treatment of Corticosteroid-refractory Autoimmune Uveitis:Pilot Study NCT01261169 | Genovate Biotechnology Co., Ltd., | — |
| Completed | Microperimetry in Macular Edema NCT00791726 | St. Franziskus Hospital | — |
| Completed | Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis NCT00615693 | Novartis | Phase 2 |
| Completed | Infectious Causes of Uveitis NCT00676624 | Statens Serum Institut | — |
| Completed | Genetics and Markers of Degenerative and Inflammatory Eye Diseases NCT00647439 | National Eye Institute (NEI) | — |
| Completed | Influencing Factors in Uveitis NCT00827086 | St. Franziskus Hospital | — |
| Completed | Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis NCT00525902 | Oregon Health and Science University | Phase 2 |
| Completed | Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A NCT00803816 | Carsten Heinz | Phase 2 |
| Completed | Intraocular Pressure (IOP) Assessed by Dynamic Contour Tonometer (DCT) and Goldman Applanation Tonometry (GAT) NCT00552019 | St. Franziskus Hospital | — |
| Withdrawn | A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis NCT00499551 | Asociación para Evitar la Ceguera en México | Phase 1 / Phase 2 |
| Terminated | Human Samples and Data Repository NCT00539370 | National Eye Institute (NEI) | — |
| Completed | Lucentis for Inflammatory Macular Edema Trial NCT00498355 | University of California, San Francisco | Phase 1 / Phase 2 |
| Completed | The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease NCT00331331 | National Eye Institute (NEI) | — |
| Completed | Phase 2 Study of MM-093 to Treat Patients With Uveitis NCT00444743 | Merrimack Pharmaceuticals | Phase 2 |
| Completed | Eye and Immunogenetic Features of Sarcoidosis NCT00379275 | National Eye Institute (NEI) | — |
| Unknown | Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial) NCT00348153 | Heidelberg University | Phase 2 / Phase 3 |
| Unknown | Quality of Life and Visual Function in Uveitis Patients NCT00407316 | The New York Eye & Ear Infirmary | — |
| Completed | Quality of Life in Juvenile Patients With Uveitis NCT01495767 | Hospital Hietzing | — |
| Completed | Efalizumab to Treat Uveitis NCT00280826 | National Eye Institute (NEI) | Phase 1 |
| Terminated | Study to Treat Uveitis Associated Macular Edema NCT00114062 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Multicenter Uveitis Steroid Treatment (MUST) Trial NCT00132691 | JHSPH Center for Clinical Trials | Phase 4 |
| Completed | Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications NCT00476593 | Norwegian University of Science and Technology | N/A |
| Completed | Acrylate Intraocular Lenses in Cataract Surgery of Uveitis Patients NCT00403832 | St. Franziskus Hospital | N/A |
| Completed | Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study NCT00116090 | National Eye Institute (NEI) | — |
| Completed | Uveitis Gene-Expression Profiling NCT00874471 | Oregon Health and Science University | — |
| Completed | Immune Indicators of Uveitis NCT00089739 | National Eye Institute (NEI) | — |
| Completed | Daclizumab and Sirolimus to Treat Uveitis NCT00078689 | National Eye Institute (NEI) | Phase 1 |
| Completed | Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment NCT00543296 | Duke University | Phase 4 |
| Terminated | Use of Thalidomide in Chronic Uveitis NCT00314665 | University of Cincinnati | Phase 4 |
| Completed | Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis NCT00070759 | National Eye Institute (NEI) | Phase 2 |
| Completed | Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis NCT00407056 | Sirion Therapeutics, Inc. | Phase 3 |
| Completed | Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis NCT00043667 | National Eye Institute (NEI) | Phase 2 |
| Completed | Differences in Genes and Proteins in Active and Controlled Uveitis NCT00357266 | National Eye Institute (NEI) | — |
| Completed | Epidemiology and Clinical Features of Uveitis in a Tertiary Referral NCT03646890 | University Hospital, Montpellier | — |
| Completed | A Clinical Trial of Infliximab for Uveitis NCT00273390 | Oregon Health and Science University | N/A |
| Completed | Vitamin E to Treat Uveitis-Associated Macular Edema NCT00021645 | National Eye Institute (NEI) | Phase 1 |
| Completed | Effect of Pregnancy on Uveitis NCT00001867 | National Eye Institute (NEI) | — |
| Completed | HAT in Eye Complications of Behcet's Disease NCT00001865 | National Eye Institute (NEI) | Phase 2 |
| Completed | Leflunomide to Treat Uveitis NCT00001863 | National Eye Institute (NEI) | Phase 2 |
| Completed | TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis NCT00001862 | National Eye Institute (NEI) | Phase 2 |
| Completed | Vascular Endothelial Growth Factor (VEGF) in Uveitis NCT00001738 | National Eye Institute (NEI) | — |
| Completed | Cyclosporin Implant to Treat Uveitis NCT00001737 | National Eye Institute (NEI) | Phase 1 |
| Completed | Screening for NEI Clinical Studies NCT00001734 | National Eye Institute (NEI) | — |
| Completed | The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis NCT00001614 | National Eye Institute (NEI) | Phase 1 |
| Completed | ANTI-TAC THERAPY FOR UVEITIS NCT00001526 | National Eye Institute (NEI) | Phase 1 |
| Completed | Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity NCT03941184 | Mayo Clinic | — |
| Unknown | Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis NCT00000119 | National Eye Institute (NEI) | Phase 2 |
| Terminated | Tissue Studies of Human Eye Diseases NCT00001310 | National Eye Institute (NEI) | — |
| Completed | Cyclosporine A in the Treatment of Juvenile Idiopathic Arthritis (JIA) Associated Chronic Anterior Uveitis NCT00404482 | St. Franziskus Hospital | — |
| Completed | Analysis of Eye Tissue NCT00001224 | National Eye Institute (NEI) | — |
| Unknown | Collaborative Ocular Melanoma Study (COMS) NCT00000124 | National Eye Institute (NEI) | Phase 3 |
| Completed | Study of Difluprednate in the Treatment of Uveitis NCT00501579 | Sirion Therapeutics, Inc. | Phase 3 |
| Unknown | The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile NCT00012506 | National Eye Institute (NEI) | Phase 3 |
| Completed | Corneal Specular Microscopy in Infectious and Noninfectious Uveitis NCT00789984 | Federal University of São Paulo | — |
| Unknown | The Comparison Between the Therapeutic Affect of Intravitreal Diclophenac and Triamcinolone in Persistent Uvei NCT00893854 | Shahid Beheshti University of Medical Sciences | Phase 1 |